Studies in normal and neoplastic tissue have indicated expression of endosialin in tumor neovasculature within human colorectal cancer [16], breast cancer [17, 18], histiocytomas [19], highly invasive glioblastoma, anaplastic astrocytomas, metastatic carcinomas, and melanoma [20, 21]. This evidence concerns the gene CD248 and glioblastoma.